General Information of the Protein
Protein ID |
PT01651
|
||||
---|---|---|---|---|---|
Protein Name |
Dihydrofolate reductase
|
||||
Gene Name |
DHFR
|
||||
Sequence |
MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Enzyme
>
Oxidoreductase
|
||||
Function |
Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis. Binds its own mRNA and that of DHFR2.
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Mitochondrion
Cytoplasm
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000108 , CCRF-CEM
Cell Line ID: CL000220 , KB
Cell Line ID: CL000266 , L1210
Cell Line ID: CL000341 , WIL2
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Dihydrofolate reductase (DHFR) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 5 Target-related Diseases | 5 | |||
1 | Pulmonary and extrapulmonary tuberculosis [ICD-11: 1B10.Z] | ||||
2 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||
3 | Urinary tract infection [ICD-11: GC08] | ||||
4 | Bacterial infection [ICD-11: 1A00-1C4Z] | ||||
5 | Bladder cancer [ICD-11: 2C94] | ||||
Approved Drug(s) | 3 Approved Drugs | 3 | |||
1 | Aminosalicylic Acid | Approved | |||
2 | Leucovorin Calcium | Approved | |||
3 | Trimethoprim | Approved | |||
Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
1 | Iclaprim | Phase 3 | |||
2 | PIRITREXIM | Phase 2 | |||
Preclinical Drug(s) | 1 Preclinical Drug | 1 | |||
1 | 1954U89 | Preclinical |